PP_1170x120_10-25-21

Cellular and Other Innovative Therapies designated network

Aetna creates new gene therapy network

Aetna creates new gene therapy network

WOONSOCKET, R.I. — Aetna announced on Wednesday the launch of its designated Gene-based, Cellular, and Other Innovative Therapies (GCIT) network. This network is designed to enable members’ access to new therapies that treat and potentially cure rare genetic diseases, while helping to manage the high cost of these therapies. Aetna’s national GCIT network includes access

Adheris Health